If so you may qualify to participate in a 30-minute virtual survey about your experiences. Our research partners would like to better understand how people with living with mBC prevent or manage treatment-related symptoms.  

 

Those who qualify and complete the survey will receive a check for $60 as a thank you for taking the time to share their experiences.

​

Who may be eligible to participate? 

• People diagnosed with metastatic hormone receptor-positive (HR+)/HER2-negative (HR+/HER2-) or triple-negative breast cancer (TNBC)

• People who have experienced symptoms (including diarrhea) while receiving treatment for mBC or TNBC.

 

*Please note, you must be a current resident of the US and 18 or older to qualify for and participate in this study. All information shared with Pinpoint will remain confidential. 

​

Click below to find out if you qualify or to get more information.